Enter Note Done
Go to previous page in this tab
Session
  • Presentation | HFpEF in CKM Syndrome: From Mechanisms to Mitigation of Risk
  • Population
  • Bookmark Icon
  • Time in Normal-High Potassium Range and Cardiovascular Outcomes in Cardio-Kidney-Metabolic Syndrome: A FINE-HEART Analysis
  • Schedule
    Notes
  • MDP1761
    Set Timezone
  •  
    View Map

Generic 'disconnected' Message
Henri Lu, Lausanne Univ Hosp, Lausanne, Switzerland; Brian Claggett, Brigham and Women's Hosp, Boston, MA; Gerasimos Filippatos, NKUA, Chaidari, Greece; Akshay S Desai, Brigham Womens Hosp, Boston, MA; Pardeep S Jhund, Alasdair David Henderson, Univ of Glasgow, Glasgow, United Kingdom; Carolyn SP Lam, Natl Heart Ctr Singapore, Singapore, Singapore; MICHELE SENNI, Asst Papa Giovanni XXIII, Bergamo, Italy; Sanjiv J Shah, Feinberg Cardiovascular Res Inst, Northwestern Univ Feinberg Sch of Med, Chicago, IL; Adriaan A Voors, Univ Medical Ctr Groningen, Groningen, Netherlands; Orly Vardeny, Minneapolis VA Health Care System, Minneapolis, MN; Faiez ZANNAD, CVCT and Univ de Lorraine, Paris, France; Peter Rossing, Steno Diabetes Ctr Copenhagen, Gentofte, Denmark; Luis M Ruilope, Hosp 12 de Octubre, Madrid, Spain; Stefan D Anker, Charite, Berlin, Germany; Bertram Pitt, Univ of Michigan Sch, Ann Arbor, MI; Flaviana Amarante, Bayer AG, Sao Paulo SP, Brazil; Andrea Glasauer, Bayer AG, Berlin, Germany; James Lay-Flurrie, Bayer plc, Reading, United Kingdom; Rajiv Agarwal, VA Indianapolis, Indianapolis, IN; Kieran Docherty, Univ of Glasgow, Glasgow, United Kingdom; John J McMurray, BHF Cardiovascular Res Ctr, Glasgow, United Kingdom; Scott Solomon, Brigham and Women's Hosp, Boston, MA; Muthiah Vaduganathan, Brigham and Womens Hosp, Boston, MA
Communities
Navigation
Session Type
Onsite Viewing
Main Session